| Q3 2023 Trading Statement
Three months ended 30 September 2023
1.
2.
Appendix
Cautionary note regarding forward-looking statements
This document contains certain statements that are, or may be deemed to be, "forward-looking
statements“ (including for purposes of the safe harbor provisions for forward-looking statements contained
in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934).
Forward-looking statements give Haleon’s current expectations and projections about future events,
including strategic initiatives and future financial condition and performance, and so Haleon’s actual results
may differ materially from what is expressed or implied by such forward-looking statements. Forward-looking statements sometimes use words such as "expects“, "anticipates“, "believes“, "targets“, "plans",
"intends“, “aims”, "projects“, "indicates", "may", “might”, "will", "should“, “potential”, “could” and words
of similar meaning (or the negative thereof). All statements, other than statements of historical facts,
included in this presentation are forward-looking statements. Such forward-looking statements include,
but are not limited to, statements relating to future actions, prospective products or product approvals,
future performance or results of current and anticipated products, sales efforts, expenses, the outcome of
contingencies such as legal proceedings, dividend payments and financial results.
Any forward-looking statements made by or on behalf of Haleon speak only as of the date they are made
and are based upon the knowledge and information available to Haleon on the date of this document.
These forward-looking statements and views may be based on a number of assumptions and, by their
nature, involve known and unknown risks, uncertainties and other factors because they relate to events
and depend on circumstances that may or may not occur in the future and/or are beyond Haleon’s control
or precise estimate. Such risks, uncertainties and other factors that could cause Haleon’s actual results,
performance or achievements to differ materially from those in the forward-looking statements include,
but are not limited to, those discussed under “Risk Factors” on pages 202 to 210 in Haleon’s Annual Report
and Form 20-F 2022. Forward-looking statements should, therefore, be construed in light of such risk
factors and undue reliance should not be placed on forward-looking statements.
Subject to our obligations under English and U.S. law in relation to disclosure and ongoing information
(including under the Market Abuse Regulations, the UK Listing Rules and the Disclosure and Transparency
Rules of the Financial Conduct Authority ("FCA")), we undertake no obligation to update publicly or revise
any forward-looking statements, whether as a result of new information, future events or otherwise. You
should, however, consult any additional disclosures that Haleon may make in any documents which it
publishes and/or files with the SEC and take note of these disclosures, wherever you are located.
No statement in this document is or is intended to be a profit forecast or profit estimate.
Use of non-IFRS measures (unaudited)
We use certain alternative performance measures to make financial, operating, and planning decisions
and to evaluate and report performance. We believe these measures provide useful information to
investors and as such, where clearly identified, we have included certain alternative performance measures
in this document to allow investors to better analyse our business performance and allow greater
comparability. To do so, we have excluded items affecting the comparability of period-over-period financial
performance. Adjusted Results and other non-IFRS measures may be considered in addition to, but not as
a substitute for or superior to, information presented in accordance with IFRS. |